Intended Use

The diagnostic ultrasound system and transducers are designed to obtain ultrasound images and analyze body fluids for a variety of clinical applications including fetal/obstetrics, abdominal, gynecology, intra-operative, pediatric, musculoskeletal, cardiac (adult and pediatric), thoracic, trans-esophageal cardiac, and peripheral vessels.

Technology

The system is a mobile, software-controlled diagnostic ultrasound device that supports multiple imaging and Doppler modes including 2D, color Doppler, power Doppler, pulsed and continuous wave Doppler, tissue Doppler imaging/wave, ElastoScan, combined modes, and 3D/4D imaging. It incorporates AI-based nerve segmentation (NerveTrack) validated on diverse patient data, providing real-time acoustic output display and advanced imaging features.

Performance

Performance testing included validation of the AI-based NerveTrack segmentation algorithm with accuracy >90% and speed >3.6 FPS across BMI subgroups. Segmentation accuracy was above 98% with clinical ground truth established by experienced anesthesiologists and sonographers. Non-clinical tests covered acoustic output, biocompatibility, software validation, electrical, mechanical and electromagnetic safety, all meeting applicable FDA standards. No new clinical studies were required for substantial equivalence.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    3/6/2024

    3 months
  • 2

    FDA Approval

    6/21/2024

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.